Chemical and Antiplasmodial Investigations on Eremophila -Derived Alkaloids and Semisynthetic Ether Analogues

Chen Zhang,Kah Yean Lum,Jonathan M. White,Sandra Duffy,Aaron M. Lock,Vicky M. Avery,Rohan A. Davis
DOI: https://doi.org/10.1021/acs.jnatprod.3c01072
IF: 5.1
2024-02-28
Journal of Natural Products
Abstract:Microthecaline A (<b>1</b>), the known antiplasmodial quinoline serrulatane alkaloid from the roots of <i>Eremophila microtheca</i> F. Muell. ex Benth. (Scrophulariaceae), was targeted for isolation and subsequent use in the generation of a semisynthetic ether library. A large-scale extraction and isolation yielded the previously undescribed quinoline serrulatane microthecaline B (<b>2</b>), along with crystalline <b>1</b> that enabled the first X-ray crystallographic analysis to be undertaken on this rare alkaloid structure class. The X-ray diffraction analysis of <b>1</b> supported the absolute configuration assignment of microthecaline A, which was originally assigned by ECD data analysis. Microthecaline A (<b>1</b>) was converted into 10 new semisynthetic ether derivatives (<b>3</b>-<b>12</b>) using a diverse series of commercially available alkyl halides. Chemical structures of the new serrulatane alkaloid and semisynthetic ether analogues were assigned by spectroscopic and spectrometric analyses. Antiplasmodial evaluations of <b>1</b>-<b>12</b> showed that the semisynthetic derivative <b>5</b> elicited the most potent activity with an IC<sub>50</sub> value of 7.2 μM against <i>Plasmodium falciparum</i> 3D7 (drug-sensitive) strain.
plant sciences,chemistry, medicinal,pharmacology & pharmacy
What problem does this paper attempt to address?